Summary of article from DiaTribe, by Michael Howerton:
Experts at the ADA 2024 Scientific Sessions highlighted AI’s potential to revolutionize clinical practice through applications like automated insulin delivery and AI-augmented clinical trials. While the benefits are substantial, concerns about data security and privacy must be addressed to ensure wider adoption. AI’s integration into diabetes care promises to empower patients with more control and knowledge about their condition. The continued development of AI-driven systems and safeguards will be crucial in realizing these advancements.